Radiolabeled peptides are molecules that combine radioactive isotopes with peptides to target and visualize specific tissues or tumors in the body, enhancing diagnostic imaging and therapeutic applications. They enable precise tracking and treatment of diseases, particularly in oncology, by exploiting the specificity of peptides for certain receptors or cellular structures.
Radionuclide imaging is a crucial medical imaging technique that uses small amounts of radioactive substances to visualize and diagnose conditions within the body. This technology, by focusing on the function of tissues and organs, enables highly effective diagnostic capabilities for a range of diseases, including cancer, heart disease, and neurological disorders.